These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37144178)

  • 1. Implementing the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis: Long-term effect of a simple educational intervention.
    Reisch LM; Shucard H; Radick AC; Eguchi MM; Elder DE; Barnhill RL; Piepkorn MW; Knezevich SR; Kerr KF; Elmore JG
    JAAD Int; 2023 Jun; 11():211-219. PubMed ID: 37144178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
    Barnhill RL; Elder DE; Piepkorn MW; Knezevich SR; Reisch LM; Eguchi MM; Bastian BC; Blokx W; Bosenberg M; Busam KJ; Carr R; Cochran A; Cook MG; Duncan LM; Elenitsas R; de la Fouchardière A; Gerami P; Johansson I; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Messina J; Mihic-Probst D; Parker DC; Schmidt B; Shea CR; Scolyer RA; Tetzlaff M; Xu X; Yeh I; Zembowicz A; Elmore JG
    JAMA Netw Open; 2023 Jan; 6(1):e2250613. PubMed ID: 36630138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
    Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
    J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminology for melanocytic skin lesions and the MPATH-Dx classification schema: A survey of dermatopathologists.
    Radick AC; Reisch LM; Shucard HL; Piepkorn MW; Kerr KF; Elder DE; Barnhill RL; Knezevich SR; Oster N; Elmore JG
    J Cutan Pathol; 2021 Jun; 48(6):733-738. PubMed ID: 32935869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.
    Piepkorn MW; Barnhill RL; Elder DE; Knezevich SR; Carney PA; Reisch LM; Elmore JG
    J Am Acad Dermatol; 2014 Jan; 70(1):131-41. PubMed ID: 24176521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma.
    Katz I; O'Brien B; Clark S; Thompson CT; Schapiro B; Azzi A; Lilleyman A; Boyle T; Espartero LJL; Yamada M; Prow TW
    JAMA Netw Open; 2021 Dec; 4(12):e2134614. PubMed ID: 34889949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPATH-Dx version 2.0 schema for melanocytic lesions: A robust tool for standardized diagnostic reporting.
    Barnhill RL; Piepkorn MW; Duncan LM; Knezevich S; Elmore JG; Elder DE
    Clin Dermatol; 2024 Sep; ():. PubMed ID: 39260462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of multiple diagnostic terms in melanocytic skin lesion pathology reports.
    Chang OH; Elder DE; Barnhill RL; Piepkorn MW; Eguchi MM; Knezevich SR; Lee AC; Moreno RJ; Kerr KF; Elmore JG
    J Cutan Pathol; 2022 Feb; 49(2):153-162. PubMed ID: 34487353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.
    Lott JP; Boudreau DM; Barnhill RL; Weinstock MA; Knopp E; Piepkorn MW; Elder DE; Knezevich SR; Baer A; Tosteson ANA; Elmore JG
    JAMA Dermatol; 2018 Jan; 154(1):24-29. PubMed ID: 29094145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions.
    Onega T; Barnhill RL; Piepkorn MW; Longton GM; Elder DE; Weinstock MA; Knezevich SR; Reisch LM; Carney PA; Nelson HD; Radick AC; Elmore JG
    JAMA Dermatol; 2018 Oct; 154(10):1159-1166. PubMed ID: 30140929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.
    Carney PA; Reisch LM; Piepkorn MW; Barnhill RL; Elder DE; Knezevich S; Geller BM; Longton G; Elmore JG
    J Cutan Pathol; 2016 Oct; 43(10):830-7. PubMed ID: 27247109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardized approach to classifying melanocytic neoplasms? Comments on the MPATH-Dx system.
    Clarke LE; Hosler GA
    J Cutan Pathol; 2021 Jun; 48(6):730-732. PubMed ID: 33617000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection.
    Amara SV; Grbic N; Melson G; Brem CE; Almier N; Bhawan J; Alani RM; Collard M
    Melanoma Res; 2023 Aug; 33(4):283-292. PubMed ID: 37276030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
    Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
    JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
    Tosteson ANA; Tapp S; Titus LJ; Nelson HD; Longton GM; Bronson M; Pepe M; Carney PA; Onega T; Piepkorn MW; Knezevich SR; Barnhill R; Weinstock MA; Elder DE; Elmore JG
    JAMA Dermatol; 2021 Sep; 157(9):1102-1106. PubMed ID: 34076664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the Histopathological Diagnosis of Non-Melanocytic Lesions Excised to Exclude Melanoma.
    Katz I; Azzi T; Lilleyman A; O'Brien B; Schapiro B; Thompson C; Prow T
    Dermatol Pract Concept; 2021 Oct; 11(4):e2021094. PubMed ID: 35024222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.
    Carney PA; Frederick PD; Reisch LM; Knezevich S; Piepkorn MW; Barnhill RL; Elder DE; Geller BM; Titus L; Weinstock MA; Nelson HD; Elmore JG
    J Am Acad Dermatol; 2016 Feb; 74(2):317-24; quiz 324.e1-8. PubMed ID: 26559597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Prior Diagnoses on Dermatopathologists' Interpretations of Melanocytic Lesions: A Randomized Controlled Trial.
    Elmore JG; Eguchi MM; Barnhill RL; Reisch LM; Elder DE; Piepkorn MW; Brunyé TT; Radick AC; Shucard HL; Knezevich SR; Kerr KF
    JAMA Dermatol; 2022 Sep; 158(9):1040-1047. PubMed ID: 35947391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.
    Elder DE; Piepkorn MW; Barnhill RL; Longton GM; Nelson HD; Knezevich SR; Pepe MS; Carney PA; Titus LJ; Onega T; Tosteson ANA; Weinstock MA; Elmore JG
    J Am Acad Dermatol; 2018 Jul; 79(1):52-59.e5. PubMed ID: 29524584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
    Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
    JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.